Valuation: MedPacto, Inc.

Market Cap 10TCr 7.84Cr 7.02Cr 6.46Cr 5.85Cr 11Cr 744.21Cr 11Cr 77Cr 31Cr 391.47Cr 29Cr 29Cr 1.23TCr P/E 2024
-7.42x
P/E 2025 -17.9x
Enterprise Value 6.56TCr 4.92Cr 4.4Cr 4.05Cr 3.67Cr 6.86Cr 466.76Cr 6.99Cr 48Cr 19Cr 245.53Cr 18Cr 18Cr 774.31Cr EV / Sales 2024
-
EV / Sales 2025 4,87,33,025x
Free-Float
74%
Yield 2024 *
-
Yield 2025 -
1 day+2.69%
1 week-0.16%
Current month+7.77%
1 month+7.77%
3 months+36.16%
6 months-40.43%
Current year-54.34%
1 week 2,865
Extreme 2865
3,135
1 month 2,705
Extreme 2705
3,600
Current year 2,235
Extreme 2235
7,980
1 year 2,235
Extreme 2235
8,650
3 years 2,235
Extreme 2235
17,240
5 years 2,235
Extreme 2235
69,600
10 years 2,235
Extreme 2235
1,34,200
Manager TitleAgeSince
Chief Executive Officer 72 19/06/2013
President 66 28/03/2024
Comptroller/Controller/Auditor 70 28/03/2022
Director TitleAgeSince
Director/Board Member 72 19/06/2013
Director/Board Member 66 28/03/2024
Director/Board Member 64 28/03/2024
Date Insider Type Main position Quantity % Market Cap. Importance
04/03/25 Buy 10,000 0.0292%
04/03/25 Buy 10,500 0.0306%
04/03/25 Buy

Chairperson

15,000 0.0438%
Change 5-day change 1-year change 3-year change Capi.($)
+2.69%-0.16%-26.42%-58.84% 7.59Cr
-0.62%-1.87%+46.31%+56.99% 6.44TCr
+0.35%+3.20%+14.92%+84.55% 5.62TCr
+0.53%+1.96%+15.37%+106.81% 5.42TCr
-2.81%-4.31%+23.50%+50.90% 4.53TCr
-0.33%-1.93%+20.15%+98.45% 4.22TCr
+0.55%+2.31%+224.97%+942.56% 4.08TCr
+3.27%+47.96%+112.67%+96.48% 3.38TCr
+1.22%-1.44%+14.89%+47.15% 3.22TCr
+0.89%+20.55%-42.03%+373.03% 2.44TCr
Average +0.57%+6.23%+40.43%+179.81% 3.94TCr
Weighted average by Cap. +0.16%+4.83%+48.29%+185.42%

Financials

2024 2025
Net sales - 3.9T 2.92 2.62 2.41 2.18 4.08 277.53 4.15 28.71 11.53 145.99 10.97 10.74 460.39
Net income -2.01TCr -1.51Cr -1.35Cr -1.24Cr -1.13Cr -2.11Cr -143.38Cr -2.15Cr -15Cr -5.96Cr -75Cr -5.67Cr -5.55Cr -237.85Cr -1.28TCr -96.05L -86.02L -79.13L -71.69L -1.34Cr -91Cr -1.37Cr -9.44Cr -3.79Cr -48Cr -3.6Cr -3.53Cr -151.29Cr
Net Debt -5.35TCr -4.01Cr -3.59Cr -3.31Cr -3Cr -5.6Cr -381.13Cr -5.71Cr -39Cr -16Cr -200.49Cr -15Cr -15Cr -632.26Cr -3.9TCr -2.92Cr -2.62Cr -2.41Cr -2.18Cr -4.08Cr -277.45Cr -4.15Cr -29Cr -12Cr -145.95Cr -11Cr -11Cr -460.26Cr
Projected Income Statement - Annual - MedPacto, Inc.
Logo MedPacto, Inc.
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Employees
56
Date Price Change Volume
30/26/30 ₩3,050.00 +2.69% 1,03,226
29/26/29 ₩2,970.00 +1.54% 92,922
28/26/28 ₩2,925.00 -2.99% 84,842
27/26/27 ₩3,015.00 -1.47% 60,988
26/26/26 ₩3,060.00 +0.16% 71,643
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - MedPacto, Inc.
  1. Stock Market
  2. Stocks
  3. A235980 Stock